Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience Q2 Operating Loss Widens To SEK 14.7 Million

Aug 13 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q2 NET SALES SEK 0 MILLION VERSUS SEK 5.8 MILLION YEAR AGO
    * Q2 OPERATING RESULT SEK -14,7 (-10,1) MILLION

Source text for Eikon:  ID:nWkrntXgT 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Sprint Bioscience AB

See all news